These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34965282)

  • 21. Reactive T Cells in Convalescent COVID-19 Patients With Negative SARS-CoV-2 Antibody Serology.
    Steiner S; Schwarz T; Corman VM; Sotzny F; Bauer S; Drosten C; Volk HD; Scheibenbogen C; Hanitsch LG
    Front Immunol; 2021; 12():687449. PubMed ID: 34322120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Three Specific Potential Epitopes That Could Be Recognized by T Cells of Convalescent COVID-19 Patients Were Identified From Spike Protein.
    Zhang Y; Yang Z; Tang M; Li H; Tang T; Li G; Zhong Y; Zhang X; Wang X; Wang C
    Front Immunol; 2022; 13():752622. PubMed ID: 35154095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunodominant T-cell epitopes from the SARS-CoV-2 spike antigen reveal robust pre-existing T-cell immunity in unexposed individuals.
    Mahajan S; Kode V; Bhojak K; Karunakaran C; Lee K; Manoharan M; Ramesh A; Hv S; Srivastava A; Sathian R; Khan T; Kumar P; Gupta R; Chakraborty P; Chaudhuri A
    Sci Rep; 2021 Jun; 11(1):13164. PubMed ID: 34162945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD4+ T cells from COVID-19 mRNA vaccine recipients recognize a conserved epitope present in diverse coronaviruses.
    Woldemeskel BA; Dykema AG; Garliss CC; Cherfils S; Smith KN; Blankson JN
    J Clin Invest; 2022 Mar; 132(5):. PubMed ID: 35061630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional characterization of CD4+ T cell receptors crossreactive for SARS-CoV-2 and endemic coronaviruses.
    Dykema AG; Zhang B; Woldemeskel BA; Garliss CC; Cheung LS; Choudhury D; Zhang J; Aparicio L; Bom S; Rashid R; Caushi JX; Hsiue EH; Cascino K; Thompson EA; Kwaa AK; Singh D; Thapa S; Ordonez AA; Pekosz A; D'Alessio FR; Powell JD; Yegnasubramanian S; Zhou S; Pardoll DM; Ji H; Cox AL; Blankson JN; Smith KN
    J Clin Invest; 2021 May; 131(10):. PubMed ID: 33830946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tetanus-diphtheria vaccine can prime SARS-CoV-2 cross-reactive T cells.
    Fernandez SA; Pelaez-Prestel HF; Fiyouzi T; Gomez-Perosanz M; Reiné J; Reche PA
    Front Immunol; 2024; 15():1425374. PubMed ID: 39091504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts.
    Kundu R; Narean JS; Wang L; Fenn J; Pillay T; Fernandez ND; Conibear E; Koycheva A; Davies M; Tolosa-Wright M; Hakki S; Varro R; McDermott E; Hammett S; Cutajar J; Thwaites RS; Parker E; Rosadas C; McClure M; Tedder R; Taylor GP; Dunning J; Lalvani A
    Nat Commun; 2022 Jan; 13(1):80. PubMed ID: 35013199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutations in SARS-CoV-2 spike protein impair epitope-specific CD4
    Tye EXC; Jinks E; Haigh TA; Kaul B; Patel P; Parry HM; Newby ML; Crispin M; Kaur N; Moss P; Drennan SJ; Taylor GS; Long HM
    Nat Immunol; 2022 Dec; 23(12):1726-1734. PubMed ID: 36456735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential T-Cell Reactivity to Endemic Coronaviruses and SARS-CoV-2 in Community and Health Care Workers.
    da Silva Antunes R; Pallikkuth S; Williams E; Dawen Yu E; Mateus J; Quiambao L; Wang E; Rawlings SA; Stadlbauer D; Jiang K; Amanat F; Arnold D; Andrews D; Fuego I; Dan JM; Grifoni A; Weiskopf D; Krammer F; Crotty S; Hoffer ME; Pahwa SG; Sette A
    J Infect Dis; 2021 Jul; 224(1):70-80. PubMed ID: 33822097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural assessment of HLA-A2-restricted SARS-CoV-2 spike epitopes recognized by public and private T-cell receptors.
    Wu D; Kolesnikov A; Yin R; Guest JD; Gowthaman R; Shmelev A; Serdyuk Y; Dianov DV; Efimov GA; Pierce BG; Mariuzza RA
    Nat Commun; 2022 Jan; 13(1):19. PubMed ID: 35013235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unbiased Screens Show CD8
    Ferretti AP; Kula T; Wang Y; Nguyen DMV; Weinheimer A; Dunlap GS; Xu Q; Nabilsi N; Perullo CR; Cristofaro AW; Whitton HJ; Virbasius A; Olivier KJ; Buckner LR; Alistar AT; Whitman ED; Bertino SA; Chattopadhyay S; MacBeath G
    Immunity; 2020 Nov; 53(5):1095-1107.e3. PubMed ID: 33128877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Novel Candidate CD8
    Pushpakumara PD; Madhusanka D; Dhanasekara S; Jeewandara C; Ogg GS; Malavige GN
    Viruses; 2021 May; 13(6):. PubMed ID: 34073934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross-reactive CD4
    Loyal L; Braun J; Henze L; Kruse B; Dingeldey M; Reimer U; Kern F; Schwarz T; Mangold M; Unger C; Dörfler F; Kadler S; Rosowski J; Gürcan K; Uyar-Aydin Z; Frentsch M; Kurth F; Schnatbaum K; Eckey M; Hippenstiel S; Hocke A; Müller MA; Sawitzki B; Miltenyi S; Paul F; Mall MA; Wenschuh H; Voigt S; Drosten C; Lauster R; Lachman N; Sander LE; Corman VM; Röhmel J; Meyer-Arndt L; Thiel A; Giesecke-Thiel C
    Science; 2021 Oct; 374(6564):eabh1823. PubMed ID: 34465633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of Serum Cross-Reactive Antibodies and Memory Response to SARS-CoV-2 in Prepandemic and Post-COVID-19 Convalescent Samples.
    Shrwani K; Sharma R; Krishnan M; Jones T; Mayora-Neto M; Cantoni D; Temperton NJ; Dobson SL; Subramaniam K; McNamara PS; Cunliffe NA; Turtle L; Zhang Q
    J Infect Dis; 2021 Oct; 224(8):1305-1315. PubMed ID: 34161567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mapping SARS-CoV-2 Antibody Epitopes in COVID-19 Patients with a Multi-Coronavirus Protein Microarray.
    Camerini D; Randall AZ; Trappl-Kimmons K; Oberai A; Hung C; Edgar J; Shandling A; Huynh V; Teng AA; Hermanson G; Pablo JV; Stumpf MM; Lester SN; Harcourt J; Tamin A; Rasheed M; Thornburg NJ; Satheshkumar PS; Liang X; Kennedy RB; Yee A; Townsend M; Campo JJ
    Microbiol Spectr; 2021 Oct; 9(2):e0141621. PubMed ID: 34704808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SARS-CoV-2 Epitopes Are Recognized by a Public and Diverse Repertoire of Human T Cell Receptors.
    Shomuradova AS; Vagida MS; Sheetikov SA; Zornikova KV; Kiryukhin D; Titov A; Peshkova IO; Khmelevskaya A; Dianov DV; Malasheva M; Shmelev A; Serdyuk Y; Bagaev DV; Pivnyuk A; Shcherbinin DS; Maleeva AV; Shakirova NT; Pilunov A; Malko DB; Khamaganova EG; Biderman B; Ivanov A; Shugay M; Efimov GA
    Immunity; 2020 Dec; 53(6):1245-1257.e5. PubMed ID: 33326767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD8 T cell epitope generation toward the continually mutating SARS-CoV-2 spike protein in genetically diverse human population: Implications for disease control and prevention.
    Guo E; Guo H
    PLoS One; 2020; 15(12):e0239566. PubMed ID: 33301503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cross-Recognition of SARS-CoV-2 B-Cell Epitopes with Other Betacoronavirus Nucleoproteins.
    Tajuelo A; López-Siles M; Más V; Pérez-Romero P; Aguado JM; Briz V; McConnell MJ; Martín-Galiano AJ; López D
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunopeptidome profiling of human coronavirus OC43-infected cells identifies CD4 T cell epitopes specific to seasonal coronaviruses or cross-reactive with SARS-CoV-2.
    Becerra-Artiles A; Nanaware PP; Muneeruddin K; Weaver GC; Shaffer SA; Calvo-Calle JM; Stern LJ
    bioRxiv; 2022 Dec; ():. PubMed ID: 36482973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conservation of HLA Spike Protein Epitopes Supports T Cell Cross-Protection in SARS-CoV-2 Vaccinated Individuals against the Potentially Zoonotic Coronavirus Khosta-2.
    Martín-Galiano AJ; López D
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.